EDAP TMS S.A. (EDAP)

Market Cap	134.99M +55.9%
Revenue (ttm)	70.53M -10.4%
Net Income	-29.25M
EPS	-0.78
Shares Out	37.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	58,620
Open	3.700
Previous Close	3.730
Day's Range	3.450 - 3.700
52-Week Range	1.210 - 5.050
Beta	-0.17
Analysts	Hold
Price Target	2.00 (-44.47%)
Earnings Date	Mar 25, 2026

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also ...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 310
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://focalone.com

Financial Performance

In 2025, EDAP TMS's revenue was 60.07 million, a decrease of -10.38% compared to the previous year's 67.03 million. Losses were -24.91 million, 25.3% more than in 2024.

Financial numbers in EUR

Analyst Summary

According to one analyst, the rating for EDAP stock is "Hold" and the 12-month stock price target is $2.0.

Price Target

$2.0

(-44.47% downside)

Analyst Consensus: Hold